Juvena Therapeutics

BiotechnologySeries BRedwood City, USjuvenatherapeutics.com

Latest round

Series B

Last raised

Jun 2025

Total raised

$82M

Investors

14

About Juvena Therapeutics

Based in California, US, Juvena Therapeutics Inc. operates as a biotech firm that develops biologics for aging-related diseases. The company was founded by its CEO Hanadie Yousef, and CSO Jeremy O’Connell. In November 2022, Juvena Therapeutics Inc. Juvena Therapeutics provides an artificial intelligence-based biologics drug development platform that is a machine learning-enabled platform for drug discovery and creates stem cell-secreted proteins and biologics for age- and chronic-related disorders. The company develops drugs through its pipeline project, JUV-161, which is a fusion protein therapeutic programme used for the treatment of neuromuscular diseases.

Who invested in Juvena Therapeutics

14 investors across 2 rounds

See all investors in Juvena Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jun 27, 2025

    Amount

    $30M

    Investors

    Locked

  2. Series A

    May 16, 2022

    Amount

    $51M

    Investors

    Locked

Questions about Juvena Therapeutics

Who invested in Juvena Therapeutics?

Juvena Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Juvena Therapeutics raised?

Juvena Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Juvena Therapeutics last raise money?

Juvena Therapeutics's most recent round on record is a Series B, in Jun 2025.

What does Juvena Therapeutics do?

Based in California, US, Juvena Therapeutics Inc.

Where is Juvena Therapeutics headquartered?

Juvena Therapeutics is headquartered in Redwood City, US.

Which VCs invest in companies like Juvena Therapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Juvena Therapeutics's stage. Their profiles are linked below.

Raising like Juvena Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.